Literature DB >> 9578397

Localization of alpha2C-adrenergic receptor immunoreactivity in catecholaminergic neurons in the rat central nervous system.

A Lee1, A E Wissekerke, D L Rosin, K R Lynch.   

Abstract

Given the importance of alpha2-adrenergic receptors in the regulation of catecholaminergic transmission, we analysed the distribution of immunoreactivity corresponding to the C-subtype of alpha2-adrenergic receptor in central catecholaminergic neurons using double-label immunohistochemistry with antibodies directed against alpha2C-adrenergic receptors and tyrosine hydroxylase. Cells exhibiting both alpha2C-adrenergic receptor and tyrosine hydroxylase immunoreactivity were found in most areas containing catecholaminergic cell groups. However, the percentage of double-labelled cells varied in a region-specific manner. In the medulla, alpha2C-adrenergic receptor immunoreactivity was characteristic of only a minority of cells exhibiting tyrosine hydroxylase immunoreactivity (40-43% in area A1/C1, 27-36% in area A2/C2, 35% in area C3) while a larger percentage of double-labelled cells was observed in the pons (65% in A5, 92% in locus coeruleus, 68% in A7). In the midbrain, alpha2C-adrenergic receptor immunoreactivity was detected in most tyrosine hydroxylase-immunoreactive cells in dopaminergic regions (63% in the retrorubral field, 77-83% in substantia nigra, 67% in ventral tegmental area). These results suggest that alpha2C-adrenergic receptors may act as autoreceptors on some central adrenergic and noradrenergic neurons. In addition, the colocalization of alpha2C-adrenergic receptor and tyrosine hydroxylase immunoreactivity in dopaminergic cell groups suggests that reported effects of alpha2-adrenergic receptor agonists in these areas may be mediated by the C-subtype.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9578397     DOI: 10.1016/s0306-4522(97)00578-2

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  17 in total

1.  Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons.

Authors:  Masato Hara; Ryuichi Fukui; Eriko Hieda; Mahomi Kuroiwa; Helen S Bateup; Tatsuhiko Kano; Paul Greengard; Akinori Nishi
Journal:  J Neurochem       Date:  2010-03-04       Impact factor: 5.372

2.  Comparison of the VTA and LC response to methylphenidate: a concomitant behavioral and neuronal study of adolescent male rats.

Authors:  Tahseen J Karim; Cruz Reyes-Vazquez; Nachum Dafny
Journal:  J Neurophysiol       Date:  2017-06-14       Impact factor: 2.714

Review 3.  Noradrenergic Modulation on Dopaminergic Neurons.

Authors:  Meng-Yang Zhu
Journal:  Neurotox Res       Date:  2018-03-23       Impact factor: 3.911

Review 4.  Alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder.

Authors:  L Cinnamon Bidwell; Rachel E Dew; Scott H Kollins
Journal:  Curr Psychiatry Rep       Date:  2010-10       Impact factor: 5.285

5.  The alpha2-adrenoceptor antagonist atipamezole reduces the development and expression of d-amphetamine-induced behavioural sensitization.

Authors:  Juuso Juhila; Antti Haapalinna; Jouni Sirviö; Jukka Sallinen; Aapo Honkanen; Esa R Korpi; Mika Scheinin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-14       Impact factor: 3.000

6.  α2A- and α2C-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands.

Authors:  Marta Sánchez-Soto; Verònica Casadó-Anguera; Hideaki Yano; Brian Joseph Bender; Ning-Sheng Cai; Estefanía Moreno; Enric I Canela; Antoni Cortés; Jens Meiler; Vicent Casadó; Sergi Ferré
Journal:  Mol Neurobiol       Date:  2018-03-18       Impact factor: 5.590

7.  Adrenergic and noradrenergic innervation of the midbrain ventral tegmental area and retrorubral field: prominent inputs from medullary homeostatic centers.

Authors:  Carlos A Mejías-Aponte; Candice Drouin; Gary Aston-Jones
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

8.  Inhibition of pontine noradrenergic A7 cells reduces hypoglossal nerve activity in rats.

Authors:  V B Fenik; I Rukhadze; L Kubin
Journal:  Neuroscience       Date:  2008-09-11       Impact factor: 3.590

9.  Clonidine and guanfacine attenuate phencyclidine-induced dopamine overflow in rat prefrontal cortex: mediating influence of the alpha-2A adrenoceptor subtype.

Authors:  J David Jentsch; Diana Sanchez; John D Elsworth; Robert H Roth
Journal:  Brain Res       Date:  2008-10-18       Impact factor: 3.252

10.  Presynaptic inhibition of glutamate transmission by α2 receptors in the VTA.

Authors:  Carlos A Jiménez-Rivera; Johnny Figueroa; Rafael Vázquez-Torres; María E Vélez-Hernandez; David Schwarz; María C Velásquez-Martinez; Francisco Arencibia-Albite
Journal:  Eur J Neurosci       Date:  2012-05       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.